Journal
FRONTIERS IN IMMUNOLOGY
Volume 6, Issue -, Pages 1-19Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2015.00362
Keywords
CD1d; antigen presentation; lipid antigens; glycosphingolipids; phospholipids; inflammation; infection; cancer
Categories
Funding
- US National Institutes of Health [5K08AI077795, 1R21AI103616]
- William F. Milton Fund
Ask authors/readers for more resources
Natural killer T (NKT) cells comprise a family of specialized T cells that recognize lipid antigens presented by CD1d. Based on their T cell receptor (TCR) usage and antigen specificities, CD1d-restricted NKT cells have been divided into two main subsets: type I NKT cells that use a canonical invariant TCR alpha-chain and recognize alpha-galactosylceramide (alpha-GalCer), and type II NKT cells that use a more diverse alpha beta TCR repertoire and do not recognize alpha-GalCer. In addition, alpha-GalCer-reactive NKT cells that use non-canonical alpha beta TCRs and CD1d-restricted T cells that use gamma delta or delta/alpha beta TCRs have recently been identified, revealing further diversity among CD1d-restricted T cells. Importantly, in addition to their distinct antigen specificities, functional differences are beginning to emerge between the different members of the CD1d-restricted T cell family. In this review, while using type I NKT cells as comparison, we will focus on type II NKT cells and the other non-invariant CD1d-restricted T cell subsets, and discuss our current understanding of the antigens they recognize, the formation of stimulatory CD1d/antigen complexes, the modes of TCR-mediated antigen recognition, and the mechanisms and consequences of their activation that underlie their function in antimicrobial responses, anti-tumor immunity, and autoimmunity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available